Blood-brain barrier breakdown in dementia with Lewy bodies

被引:0
|
作者
Gan, Jinghuan [1 ]
Xu, Ziming [2 ]
Chen, Zhichao [1 ]
Liu, Shuai [3 ]
Lu, Hao [4 ]
Wang, Yajie [2 ]
Wu, Hao [3 ]
Shi, Zhihong [3 ]
Chen, Huijun [2 ]
Ji, Yong [3 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing, Peoples R China
[2] Tsinghua Univ, Ctr Biomed Imaging Res, Dept Biomed Engn, Beijing, Peoples R China
[3] Tianjin Huanhu Hosp, Tianjin Dementia Inst, Dept Neurol, Tianjin Key Lab Cerebrovascu & Neurodegenerat Dis, 6 Jizhao Rd, Tianjin 300350, Peoples R China
[4] Tianjin Huanhu Hosp, Dept Radiol, Tianjin, Peoples R China
来源
FLUIDS AND BARRIERS OF THE CNS | 2024年 / 21卷 / 01期
基金
中国国家自然科学基金;
关键词
Blood brain barrier; Dynamic contrast-enhanced magnetic resonance imaging; Lewy body; Alzheimer's disease; Amyloid-beta; ALZHEIMERS-DISEASE; PREVALENCE; DIAGNOSIS; PATHOLOGY; RATIO; RISK; APOE; MRI;
D O I
10.1186/s12987-024-00575-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundBlood-brain barrier (BBB) dysfunction has been viewed as a potential underlying mechanism of neurodegenerative disorders, possibly involved in the pathogenesis and progression of Alzheimer's disease (AD). However, a relation between BBB dysfunction and dementia with Lewy bodies (DLB) has yet to be systematically investigated. Given the overlapping clinical features and neuropathology of AD and DLB, we sought to evaluate BBB permeability in the context of DLB and determine its association with plasma amyloid-beta (A beta) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).MethodsFor this prospective study, we examined healthy controls (n = 24, HC group) and patients diagnosed with AD (n = 29) or DLB (n = 20) between December 2020 and April 2022. Based on DCE-MRI studies, mean rates of contrast agent transfer from intra- to extravascular spaces (Ktrans) were calculated within regions of interest. Spearman's correlation and multivariate linear regression were applied to analyze associations between Ktrans and specific clinical characteristics.ResultsIn members of the DLB (vs HC) group, Ktrans values of cerebral cortex (p = 0.024), parietal lobe (p = 0.007), and occipital lobe (p = 0.014) were significantly higher; and Ktrans values of cerebral cortex (p = 0.041) and occipital lobe (p = 0.018) in the DLB group were significantly increased, relative to those of the AD group. All participants also showed increased Ktrans values of parietal (beta\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\upbeta$$\end{document} = 0.391; p = 0.001) and occipital (beta\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\upbeta$$\end{document} = 0.357; p = 0.002) lobes that were significantly associated with higher scores of the Clinical Dementia Rating, once adjusted for age and sex. Similarly, increased Ktrans values of cerebral cortex (beta\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\upbeta$$\end{document} = 0.285; p = 0.015), frontal lobe (beta\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\upbeta$$\end{document} = 0.237; p = 0.043), and parietal lobe (beta\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\upbeta$$\end{document} = 0.265; p = 0.024) were significantly linked to higher plasma A beta 1-42/A beta 1-40 ratios, after above adjustments.ConclusionBBB leakage is a common feature of DLB and possibly is even more severe than in the setting of AD for certain regions of the brain. BBB leakage appears to correlate with plasma A beta 1-42/A beta 1-40 ratio and dementia severity.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies
    Alkhalifa, Amer E.
    Al-Ghraiybah, Nour F.
    Odum, Julia
    Shunnarah, John G.
    Austin, Nataleigh
    Kaddoumi, Amal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [22] Altered structural connectivity networks in dementia with lewy bodies
    Nicastro, Nicolas
    Mak, Elijah
    Surendranathan, Ajenthan
    Rittman, Timothy
    Rowe, James B.
    O'Brien, John T.
    BRAIN IMAGING AND BEHAVIOR, 2021, 15 (05) : 2445 - 2453
  • [23] Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry
    Graff-Radford, Jonathan
    Lesnick, Timothy G.
    Boeve, Bradley F.
    Przybelski, Scott A.
    Jones, David T.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Ferman, Tanis J.
    Knopman, David S.
    Murray, Melissa E.
    Dickson, Dennis W.
    Sarro, Lidia
    Jack, Clifford R., Jr.
    Petersen, Ronald C.
    Kantarci, Kejal
    MOVEMENT DISORDERS, 2016, 31 (07) : 989 - 994
  • [24] Imaging in Dementia With Lewy Bodies: An Overview
    Watson, Rosie
    Colloby, Sean J.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2016, 29 (05) : 254 - 260
  • [25] Familial Aggregation of Dementia With Lewy Bodies
    Nervi, Angela
    Reitz, Christiane
    Tang, Ming-Xin
    Santana, Vincent
    Piriz, Angel
    Reyes, Dolly
    Lantigua, Rafael
    Medrano, Martin
    Jimenez-Velazquez, Ivonne Z.
    Lee, Joseph H.
    Mayeux, Richard
    ARCHIVES OF NEUROLOGY, 2011, 68 (01) : 90 - 93
  • [26] A proteomic signature for dementia with Lewy bodies
    O'Bryant, Sid E.
    Ferman, Tanis J.
    Zhang, Fan
    Hall, James
    Pedraza, Otto
    Wszolek, Zbigniew K.
    Como, Tori
    Julovich, David
    Mattevada, Sravan
    Johnson, Leigh A.
    Edwards, Melissa
    Hall, James
    Graff-Radford, Neill R.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 270 - 276
  • [27] Pharmacological Management of Dementia with Lewy Bodies
    Hershey, Linda A.
    Coleman-Jackson, Rhonda
    DRUGS & AGING, 2019, 36 (04) : 309 - 319
  • [28] Tau Proteins Cross the Blood-Brain Barrier
    Banks, William A.
    Kovac, Andrej
    Majerova, Petra
    Bullock, Kristin M.
    Shi, Min
    Zhang, Jing
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (01) : 411 - 419
  • [29] Changes in CSF sPDGFRβ level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions
    Lv, Xinyi
    Zhang, Mengguo
    Cheng, Zhaozhao
    Wang, Qiong
    Wang, Peng
    Xie, Qiang
    Ni, Ming
    Shen, Yong
    Tang, Qiqiang
    Gao, Feng
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [30] Leaky memories: Impact of APOE4 on blood-brain barrier and dementia
    Li, Wenlu
    Lo, Eng H.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (09): : 1912 - 1914